Fully Human Antibody Targeting Human CD123 For Cancer Threpeutics Development
Technology
E-131-2018
Patent ID
E-131-2018-0-US-03
Country
US
Application Type
ORD
Patent Status
Pending
Patent Number
Publication Number
Application Number
16/578,063
IC
NCI
Date Filed
Date Issued
Patent PDF